Paige recognized for achievements in Computer-Aided Imaging
December 8, 2021 — CB Insights today named Paige to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year’s Digital Health 150 honorees were unveiled live during CB Insights’ annual Future of Health event.
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees. They were chosen based on several factors, including data submitted by the companies, company business models and momentum in the market, and CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.
This recognizes the monumental achievements of our Paige team over the past year, including landing the first-ever FDA approval for an AI product in pathology, completing our Series C financing and achieving numerous business development and commercialization milestones. We are proud of our team, whose work has positioned Paige for strong growth in 2022, delivering on our mission to build the next generation computational technology that unlocks insights from each tissue sample for doctors to optimize patient outcomes.
Paige was previously named to the CB Insights Digital Health 150 in 2019 and 2020 – every year since the annual list was first compiled.
